Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Accumulated Depreciation (2016 - 2021)

Historic Accumulated Depreciation for vTv Therapeutics (VTVT) over the last 8 years, with Q4 2021 value amounting to $305000.0.

  • vTv Therapeutics' Accumulated Depreciation rose 4120.37% to $305000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $305000.0, marking a year-over-year increase of 4120.37%. This contributed to the annual value of $305000.0 for FY2021, which is 4120.37% up from last year.
  • Per vTv Therapeutics' latest filing, its Accumulated Depreciation stood at $305000.0 for Q4 2021, which was up 4120.37% from $216000.0 recorded in Q4 2020.
  • vTv Therapeutics' 5-year Accumulated Depreciation high stood at $9.1 million for Q4 2017, and its period low was $148000.0 during Q4 2019.
  • In the last 5 years, vTv Therapeutics' Accumulated Depreciation had a median value of $305000.0 in 2021 and averaged $3.6 million.
  • Its Accumulated Depreciation has fluctuated over the past 5 years, first plummeted by 9824.46% in 2019, then soared by 4594.59% in 2020.
  • vTv Therapeutics' Accumulated Depreciation (Quarter) stood at $9.1 million in 2017, then dropped by 7.51% to $8.4 million in 2018, then tumbled by 98.24% to $148000.0 in 2019, then surged by 45.95% to $216000.0 in 2020, then skyrocketed by 41.2% to $305000.0 in 2021.
  • Its Accumulated Depreciation stands at $305000.0 for Q4 2021, versus $216000.0 for Q4 2020 and $148000.0 for Q4 2019.